Alcon
ALC • NYSE
Alcon is a medical - instruments & supplies company in the healthcare sector trading on NYSE, led by CEO David J. Endicott, with a market cap of $39.3B.
CEODavid J. Endicott
Next Earnings
Upcoming earnings announcement for Alcon
Date
Tuesday, May 12, 2026 (in 2 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
$0.82
Revenue Estimate
$2.7B
Earnings History
Past 12 earnings reports for Alcon
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 24, 2026 | Q4 2025 | $0.78Est: $0.84 | -7.1% | $2.7BEst: $2.7B | -0.3% | — |
| Nov 11, 2025 | Q3 2025 | $0.79Est: $0.82 | -3.7% | $2.6BEst: $2.6B | -0.2% | — |
| Aug 19, 2025 | Q2 2025 | $0.76Est: $0.72 | +5.6% | $2.6BEst: $2.6B | -2.0% | — |
| May 13, 2025 | Q1 2025 | $0.73Est: $0.77 | -5.2% | $2.5BEst: $2.5B | -2.7% | — |
| Feb 25, 2025 | Q4 2024 | $0.72Est: $0.71 | +1.4% | $2.5BEst: $2.5B | +0.3% | — |
| Nov 12, 2024 | Q3 2024 | $0.81Est: $0.74 | +9.5% | $2.4BEst: $2.5B | -1.1% | — |
| Aug 20, 2024 | Q2 2024 | $0.74Est: $0.73 | +1.4% | $2.5BEst: $2.5B | -1.5% | — |
| May 13, 2024 | Q1 2024 | $0.78Est: $0.72 | +8.3% | $2.4BEst: $2.5B | -0.7% | — |
| Feb 27, 2024 | Q4 2023 | $0.70Est: $0.68 | +2.9% | $2.3BEst: $2.3B | -0.3% | — |
| Nov 14, 2023 | Q3 2023 | $0.66Est: $0.67 | -1.5% | $2.3BEst: $2.4B | -2.0% | — |
| Aug 15, 2023 | Q2 2023 | $0.69Est: $0.63 | +9.5% | $2.4BEst: $2.4B | +1.8% | — |
| May 9, 2023 | Q1 2023 | $0.70Est: $0.60 | +16.7% | $2.3BEst: $2.2B | +4.6% | — |